Yemaachi Biotechnology provides diversifying precision cancer diagnostics and treatments.
Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2022 | Seed | $3M | 1 | — | — | Detail |
Aug 31, 2021 | Pre-seed | $425K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
V Square Capital | — | Seed |
First circle capital | — | Pre-seed |